Selected research
Market Structure
Global Niraparib API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Niraparib API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Niraparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Niraparib API include Nantong Changyou Pharmaceutical Technology, Asymchem, WuXi STA, Valary Lab, SynZeal Research, Jigs chemical, Dr. Reddy's Laboratories and Bulat Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Niraparib API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Niraparib API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Niraparib API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Niraparib API market size, projected growth trends, production technologies, key applications, and end-use industries.
Niraparib API Segment by Company
Nantong Changyou Pharmaceutical Technology
Asymchem
WuXi STA
Valary Lab
SynZeal Research
Jigs chemical
Dr. Reddy's Laboratories
Bulat Pharmaceutical
Niraparib API Segment by Type
0.98
0.99
Niraparib API Segment by Application
Tablets
Capsules
Other
Niraparib API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niraparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Niraparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niraparib API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Niraparib API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Niraparib API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Niraparib API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Niraparib API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 0.98
- 0.99
Applications
- Tablets
- Capsules
- Other
Companies covered
- Nantong Changyou Pharmaceutical Technology
- Asymchem
- WuXi STA
- Valary Lab
- SynZeal Research
- Jigs chemical
- Dr. Reddy's Laboratories
- Bulat Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Niraparib API Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Niraparib API Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Niraparib API Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Niraparib API Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Niraparib API Market Dynamics
- 2.1 Niraparib API Industry Trends
- 2.2 Niraparib API Industry Drivers
- 2.3 Niraparib API Industry Opportunities and Challenges
- 2.4 Niraparib API Industry Restraints
3 Niraparib API Market by Manufacturers
- 3.1 Global Niraparib API Revenue by Manufacturers (2021-2026)
- 3.2 Global Niraparib API Sales by Manufacturers (2021-2026)
- 3.3 Global Niraparib API Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Niraparib API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Niraparib API Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Niraparib API Manufacturers, Product Type & Application
- 3.7 Global Niraparib API Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Niraparib API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Niraparib API Players Market Share by Revenue in 2025
- 3.8.3 2025 Niraparib API Tier 1, Tier 2, and Tier 3
4 Niraparib API Market by Type
- 4.1 Niraparib API Type Introduction
- 4.1.1 0.98
- 4.1.2 0.99
- 4.2 Global Niraparib API Sales by Type
- 4.2.1 Global Niraparib API Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Niraparib API Sales by Type (2021-2032)
- 4.2.3 Global Niraparib API Sales Market Share by Type (2021-2032)
- 4.3 Global Niraparib API Revenue by Type
- 4.3.1 Global Niraparib API Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Niraparib API Revenue by Type (2021-2032)
- 4.3.3 Global Niraparib API Revenue Market Share by Type (2021-2032)
5 Niraparib API Market by Application
- 5.1 Niraparib API Application Introduction
- 5.1.1 Tablets
- 5.1.2 Capsules
- 5.1.3 Other
- 5.2 Global Niraparib API Sales by Application
- 5.2.1 Global Niraparib API Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Niraparib API Sales by Application (2021-2032)
- 5.2.3 Global Niraparib API Sales Market Share by Application (2021-2032)
- 5.3 Global Niraparib API Revenue by Application
- 5.3.1 Global Niraparib API Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Niraparib API Revenue by Application (2021-2032)
- 5.3.3 Global Niraparib API Revenue Market Share by Application (2021-2032)
6 Global Niraparib API Sales by Region
- 6.1 Global Niraparib API Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Niraparib API Sales by Region (2021-2032)
- 6.2.1 Global Niraparib API Sales by Region (2021-2026)
- 6.2.2 Global Niraparib API Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Niraparib API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Niraparib API Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Niraparib API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Niraparib API Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Niraparib API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Niraparib API Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Niraparib API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Niraparib API Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Niraparib API Revenue by Region
- 7.1 Global Niraparib API Revenue by Region
- 7.1.1 Global Niraparib API Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Niraparib API Revenue by Region (2021-2026)
- 7.1.3 Global Niraparib API Revenue by Region (2027-2032)
- 7.1.4 Global Niraparib API Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Niraparib API Revenue (2021-2032)
- 7.2.2 North America Niraparib API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Niraparib API Revenue (2021-2032)
- 7.3.2 Europe Niraparib API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Niraparib API Revenue (2021-2032)
- 7.4.2 Asia-Pacific Niraparib API Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Niraparib API Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Niraparib API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Nantong Changyou Pharmaceutical Technology
- 8.1.1 Nantong Changyou Pharmaceutical Technology Company Information
- 8.1.2 Nantong Changyou Pharmaceutical Technology Business Overview
- 8.1.3 Nantong Changyou Pharmaceutical Technology Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Nantong Changyou Pharmaceutical Technology Niraparib API Product Portfolio
- 8.1.5 Nantong Changyou Pharmaceutical Technology Recent Developments
- 8.2 Asymchem
- 8.2.1 Asymchem Company Information
- 8.2.2 Asymchem Business Overview
- 8.2.3 Asymchem Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Asymchem Niraparib API Product Portfolio
- 8.2.5 Asymchem Recent Developments
- 8.3 WuXi STA
- 8.3.1 WuXi STA Company Information
- 8.3.2 WuXi STA Business Overview
- 8.3.3 WuXi STA Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 WuXi STA Niraparib API Product Portfolio
- 8.3.5 WuXi STA Recent Developments
- 8.4 Valary Lab
- 8.4.1 Valary Lab Company Information
- 8.4.2 Valary Lab Business Overview
- 8.4.3 Valary Lab Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Valary Lab Niraparib API Product Portfolio
- 8.4.5 Valary Lab Recent Developments
- 8.5 SynZeal Research
- 8.5.1 SynZeal Research Company Information
- 8.5.2 SynZeal Research Business Overview
- 8.5.3 SynZeal Research Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 SynZeal Research Niraparib API Product Portfolio
- 8.5.5 SynZeal Research Recent Developments
- 8.6 Jigs chemical
- 8.6.1 Jigs chemical Company Information
- 8.6.2 Jigs chemical Business Overview
- 8.6.3 Jigs chemical Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Jigs chemical Niraparib API Product Portfolio
- 8.6.5 Jigs chemical Recent Developments
- 8.7 Dr. Reddy's Laboratories
- 8.7.1 Dr. Reddy's Laboratories Company Information
- 8.7.2 Dr. Reddy's Laboratories Business Overview
- 8.7.3 Dr. Reddy's Laboratories Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dr. Reddy's Laboratories Niraparib API Product Portfolio
- 8.7.5 Dr. Reddy's Laboratories Recent Developments
- 8.8 Bulat Pharmaceutical
- 8.8.1 Bulat Pharmaceutical Company Information
- 8.8.2 Bulat Pharmaceutical Business Overview
- 8.8.3 Bulat Pharmaceutical Niraparib API Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Bulat Pharmaceutical Niraparib API Product Portfolio
- 8.8.5 Bulat Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Niraparib API Value Chain Analysis
- 9.1.1 Niraparib API Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Niraparib API Production Mode & Process
- 9.2 Niraparib API Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Niraparib API Distributors
- 9.2.3 Niraparib API Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst